The impact of smoking and smoking cessation on disease outcomes in ulcerative colitis: a nationwide population-based study - PubMed (original) (raw)
. 2019 Sep;50(5):556-567.
doi: 10.1111/apt.15390. Epub 2019 Aug 6.
Affiliations
- PMID: 31389044
- DOI: 10.1111/apt.15390
Free article
The impact of smoking and smoking cessation on disease outcomes in ulcerative colitis: a nationwide population-based study
Jonathan Blackwell et al. Aliment Pharmacol Ther. 2019 Sep.
Free article
Abstract
Background: Smokers are less likely to develop ulcerative colitis (UC) but the impact of smoking and subsequent cessation on clinical outcomes in UC is unclear.
Aim: To evaluate the effect of smoking status and smoking cessation on disease outcomes.
Methods: Using a nationally representative clinical research database, we identified incident cases of UC during 2005-2016. Patients were grouped as never-smokers, ex-smokers and smokers based on smoking status recorded in the 2 years preceding UC diagnosis. We defined subgroups of persistent smokers and smokers who quit within 2 years after diagnosis. We compared the rates of overall corticosteroid use, corticosteroid-requiring flares, corticosteroid dependency, thiopurine use, hospitalisation and colectomy between these groups.
Results: We identified 6754 patients with a new diagnosis of UC over the study period with data on smoking status, of whom 878 were smokers at diagnosis. Smokers had a similar risk of corticosteroid-requiring flares (OR 1.16, 95% CI 0.92-1.25), thiopurine use (HR 0.84, 95% CI 0.62-1.14), corticosteroid dependency (HR 0.85, 95% CI 0.60-1.11), hospitalisation (HR 0.92, 95% CI 0.72-1.18) and colectomy (HR 0.78, 95% CI 0.50-1.21) in comparison with never-smokers. Rates of flares, thiopurine use, corticosteroid dependency, hospitalisation and colectomy were not significantly different between persistent smokers and those who quit smoking after a diagnosis of UC.
Conclusions: Smokers and never-smokers with UC have similar outcomes with respect to flares, thiopurine use, corticosteroid dependency, hospitalisation and colectomy. Smoking cessation was not associated with worse disease course. The risks associated with smoking outweigh any benefits. UC patients should be counselled against smoking.
© 2019 John Wiley & Sons Ltd.
Similar articles
- Associations between prior healthcare use, time to diagnosis, and clinical outcomes in inflammatory bowel disease: a nationally representative population-based cohort study.
Jayasooriya N, Saxena S, Blackwell J, Bottle A, Creese H, Petersen I, Pollok RCG; POP-IBD Collaboration. Jayasooriya N, et al. BMJ Open Gastroenterol. 2024 May 27;11(1):e001371. doi: 10.1136/bmjgast-2024-001371. BMJ Open Gastroenterol. 2024. PMID: 38802264 Free PMC article. - Smoking Status at Diagnosis and Subsequent Smoking Cessation: Associations With Corticosteroid Use and Intestinal Resection in Crohn's Disease.
Alexakis C, Saxena S, Chhaya V, Cecil E, Majeed A, Pollok R. Alexakis C, et al. Am J Gastroenterol. 2018 Nov;113(11):1689-1700. doi: 10.1038/s41395-018-0273-7. Epub 2018 Oct 15. Am J Gastroenterol. 2018. PMID: 30323269 - Impact of cessation of smoking on the course of ulcerative colitis.
Beaugerie L, Massot N, Carbonnel F, Cattan S, Gendre JP, Cosnes J. Beaugerie L, et al. Am J Gastroenterol. 2001 Jul;96(7):2113-6. doi: 10.1111/j.1572-0241.2001.03944.x. Am J Gastroenterol. 2001. PMID: 11467641 - Ulcerative colitis in smokers, non-smokers and ex-smokers.
Bastida G, Beltrán B. Bastida G, et al. World J Gastroenterol. 2011 Jun 14;17(22):2740-7. doi: 10.3748/wjg.v17.i22.2740. World J Gastroenterol. 2011. PMID: 21734782 Free PMC article. Review. - Smoking influences the need for surgery in patients with the inflammatory bowel diseases: a systematic review and meta-analysis incorporating disease duration.
Kuenzig ME, Lee SM, Eksteen B, Seow CH, Barnabe C, Panaccione R, Kaplan GG. Kuenzig ME, et al. BMC Gastroenterol. 2016 Dec 21;16(1):143. doi: 10.1186/s12876-016-0555-8. BMC Gastroenterol. 2016. PMID: 28003021 Free PMC article. Review.
Cited by
- The Role of Environmental and Nutritional Factors in the Development of Inflammatory Bowel Diseases: A Case-Control Study.
Serrano-Fernandez V, Laredo-Aguilera JA, Navarrete-Tejero C, Molina-Gallego B, Lopez-Fernandez-Roldan A, Carmona-Torres JM. Serrano-Fernandez V, et al. Nutrients. 2024 Jul 29;16(15):2463. doi: 10.3390/nu16152463. Nutrients. 2024. PMID: 39125343 Free PMC article. - Associations between prior healthcare use, time to diagnosis, and clinical outcomes in inflammatory bowel disease: a nationally representative population-based cohort study.
Jayasooriya N, Saxena S, Blackwell J, Bottle A, Creese H, Petersen I, Pollok RCG; POP-IBD Collaboration. Jayasooriya N, et al. BMJ Open Gastroenterol. 2024 May 27;11(1):e001371. doi: 10.1136/bmjgast-2024-001371. BMJ Open Gastroenterol. 2024. PMID: 38802264 Free PMC article. - Precision medicine in inflammatory bowel disease.
Zeng Z, Jiang M, Li X, Yuan J, Zhang H. Zeng Z, et al. Precis Clin Med. 2023 Dec 18;6(4):pbad033. doi: 10.1093/pcmedi/pbad033. eCollection 2023 Dec. Precis Clin Med. 2023. PMID: 38638127 Free PMC article. Review. - The Role of the Microbiome in the Pathogenesis and Treatment of Ulcerative Colitis-A Literature Review.
Świrkosz G, Szczygieł A, Logoń K, Wrześniewska M, Gomułka K. Świrkosz G, et al. Biomedicines. 2023 Nov 25;11(12):3144. doi: 10.3390/biomedicines11123144. Biomedicines. 2023. PMID: 38137365 Free PMC article. Review. - Ulcerative Colitis After Complicated Diverticulitis.
Tursi A, Nenna R, Papa V. Tursi A, et al. ACG Case Rep J. 2023 Mar 24;10(3):e01013. doi: 10.14309/crj.0000000000001013. eCollection 2023 Mar. ACG Case Rep J. 2023. PMID: 36998344 Free PMC article.
References
REFERENCES
- Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006;81:1462-1471.
- Parkes GC, Whelan K, Lindsay JO. Smoking in inflammatory bowel disease: Impact on disease course and insights into the aetiology of its effect. J Crohn’s Colitis. 2014;8:717-725.
- Lunney PC, Kariyawasam VC, Wang RR, et al. Smoking prevalence and its influence on disease course and surgery in Crohn’s disease and ulcerative colitis. Aliment Pharmacol Ther. 2015;42:61-70.
- Mokbel M, Carbonnel F, Beaugerie L, Gendre J. Effect of smoking on the long-term course of ulcerative colitis. Gastroenterol Clin Biol. 1998;22:858-862.
- van der Heide F, Dijkstra A, Weersma RK, et al. Effects of active and passive smoking on disease course of Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis. 2009;15:1199-1207.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical